Buscar resultados de ensayos clínicos
Leishmaniasis, Visceral - 19 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh Condición: Visceral Leishmaniasis Fecha: 2011-01-21 Intervenciones: Drug: Paromomycin sulfate Paromomycin IM Injection, 11 mg/kg as the base, intramuscular, once a day on 2 |
| Completed |
Nombre del estudio: A Community Trial for Visceral Leishmaniasis (VL) Condición: Visceral Leishmaniasis Fecha: 2010-02-14 Intervenciones:
|
| Completed |
Nombre del estudio: Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa Condición: Primary Visceral Leishmaniasis Fecha: 2010-02-10 Intervenciones:
|
| Completed |
Nombre del estudio: Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala Azar Condición:
|
| Completed |
Nombre del estudio: Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis Condición: Visceral Leishmaniasis Fecha: 2005-09-13 Intervenciones:
|
| Completed |
Nombre del estudio: Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa Condición: Visceral Leishmaniasis Fecha: 2015-04-20 Intervenciones: Drug: Miltefosine |
| Not yet recruiting |
Nombre del estudio: Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa Condición: Visceral Leishmaniasis Fecha: 2017-04-21 Intervenciones:
|
| Completed |
Nombre del estudio: Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis Condición: Visceral Leishmaniasis Fecha: 2008-06-11 Intervenciones:
|
| Completed |
Nombre del estudio: A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) Condición: Post-kala-azar Dermal Leishmaniasis Fecha: 2013-10-23 Intervenciones: Drug: Mitefosine Tablet Miltefosine 100 mg in two devided doses for 12 weeks |